InsiderFlow

Steve E. Krognes

DNLI

Steve E. Krognes serves as Director at Denali Therapeutics Inc. (DNLI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

18 trades

$8.02M

Net Position

Net Seller

$8.02M

Companies Traded

1

DNLI

Active Period

Mar 2021 – Jan 2025

18 total trades

Most Recent

Sell DNLI

Jan 8, 2025 · $69.5K

Steve E. Krognes's Insider Trading at Denali Therapeutics Inc. (DNLI)

Buys

0 · $0.00

Sells

18 · $8.02M

Total Shares Bought

0

Total Shares Sold

262,716

DNLI Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jan 8, 2025Sell3,339$20.81$69.5K25,757
Jan 3, 2025Sell30,000$20.25$607.5K29,096
Oct 2, 2024Sell30,000$29.03$870.9K29,096
Aug 22, 2024Sell1,727$23.79$41.1K32,677
Jul 3, 2024Sell30,688$22.11$678.7K52,620
Apr 2, 2024Sell92,500$20.50$1.90M47,341
Feb 15, 2024Sell2,750$17.29$47.5K139,841
Jan 9, 2024Sell3,208$19.43$62.3K142,591
Aug 23, 2023Sell1,419$22.60$32.1K145,799
Feb 15, 2023Sell2,119$30.10$63.8K143,002
Feb 10, 2023Sell1,377$30.88$42.5K145,121
Jan 9, 2023Sell2,970$28.44$84.5K146,498
Aug 23, 2022Sell2,253$33.22$74.8K149,468
Feb 15, 2022Sell2,560$34.69$88.8K120,221
Feb 11, 2022Sell1,296$37.09$48.1K122,781
Jan 7, 2022Sell2,225$44.75$99.6K124,077
Aug 23, 2021Sell2,285$49.57$113.3K95,502
Mar 16, 2021Sell50,000$61.89$3.09M886,742